An update on placental drug transport and its relevance to fetal drug exposure
Pregnant women are often complicated with diseases that require treatment with medication. Most drugs administered to pregnant women are off-label without the necessary dose, efficacy, and safety information. Knowledge concerning drug transfer across the placental barrier is essential for understand...
Main Authors: | Mao Qingcheng, Chen Xin |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2022-10-01
|
Series: | Medical Review |
Subjects: | |
Online Access: | https://doi.org/10.1515/mr-2022-0025 |
Similar Items
-
Comparison of the Blood–Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug–Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging
by: Louise Breuil, et al.
Published: (2022-08-01) -
Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [<sup>11</sup>C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier
by: Louise Breuil, et al.
Published: (2022-11-01) -
Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early—Stage Drug Development
by: Yvonne E. Arnold, et al.
Published: (2020-09-01) -
Transporter-Mediated Drug Delivery
by: Gergely Gyimesi, et al.
Published: (2023-01-01) -
Equine Drug Transporters: A Mini-Review and Veterinary Perspective
by: Brielle Rosa
Published: (2020-11-01)